1. Home
  2. SLGL vs NSLR Comparison

SLGL vs NSLR Comparison

Compare SLGL & NSLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

N/A

Current Price

$63.06

Market Cap

254.1M

Sector

Health Care

ML Signal

N/A

Logo Neostellar Capital Corp. Common Stock

NSLR

Neostellar Capital Corp. Common Stock

N/A

Current Price

$7.94

Market Cap

260.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SLGL
NSLR
Founded
1997
N/A
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
254.1M
260.8M
IPO Year
2016
2011

Fundamental Metrics

Financial Performance
Metric
SLGL
NSLR
Price
$63.06
$7.94
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $110.00
N/A
AVG Volume (30 Days)
52.7K
★ 464.3K
Earning Date
05-22-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 211.25
EPS
N/A
★ 4.58
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$223.84
N/A
P/E Ratio
★ N/A
$1.75
Revenue Growth
N/A
N/A
52 Week Low
$27.00
$7.60
52 Week High
$97.97
$12.19

Technical Indicators

Market Signals
Indicator
SLGL
NSLR
Relative Strength Index (RSI) 45.68 31.07
Support Level $62.21 $7.67
Resistance Level $67.85 $8.36
Average True Range (ATR) 3.08 0.44
MACD 0.11 -0.06
Stochastic Oscillator 58.87 13.37

Price Performance

Historical Comparison
SLGL
NSLR

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted. It generates the majority of its revenue from the United States.

About NSLR Neostellar Capital Corp. Common Stock

Neostellar Capital Corp is an investment company focused on private, venture-backed businesses. It invests in companies that are not yet listed on a public stock exchange. It helps investors to gain exposure to a portfolio of VC-backed companies through a publicly traded stock.

Share on Social Networks: